The global insulin delivery devices market was valued at USD 19.3 billion in 2025 and is projected to grow from USD 20.9 billion in 2026 to USD 35.2 billion by 2033, registering a CAGR of 7.8% from 2026 to 2033. North America dominated the global market in 2025, accounting for a revenue share of 40.7%. Market growth is primarily driven by the increasing global prevalence of diabetes and rising...